The document outlines the screening of hepatoprotective drugs, detailing the liver's functions, the causes of hepatotoxicity, and various hepatoprotective agents. It also describes methodologies for screening these agents, including primary hepatocyte and stellate cell culture techniques, as well as various in vivo models for assessing liver damage and protection. Comprehensive information is provided on drug-induced liver injury, the evaluation of hepatotoxicity, and specific screening procedures involving different experimental models.